These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 32222149

  • 1. Final adult height of children with idiopathic short stature: a multicenter study on GH therapy alone started during peri-puberty.
    Wu D, Chen RM, Chen SK, Liu GL, Chen LQ, Yang Y, Wang XL, Peng YG, Gong CX.
    BMC Pediatr; 2020 Mar 28; 20(1):138. PubMed ID: 32222149
    [Abstract] [Full Text] [Related]

  • 2. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ, Quigley CA, Cutler GB, Moore WV, Wintergerst KA, Ross JL, Rosenfeld RG, Blum WF.
    Horm Res Paediatr; 2019 Mar 28; 91(4):241-251. PubMed ID: 31185471
    [Abstract] [Full Text] [Related]

  • 3. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT, Elawwa A, Itani M, Jour C, De Sanctis V.
    Acta Biomed; 2019 Sep 23; 90(8-S):43-51. PubMed ID: 31544806
    [Abstract] [Full Text] [Related]

  • 4. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb 23; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 5. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
    Lazar L, Levy S, Oron T, Meyerovitch J, de Vries L, Shalitin S, Tenenbaum A, Phillip M, Lebenthal Y.
    J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3287-3295. PubMed ID: 30912806
    [Abstract] [Full Text] [Related]

  • 6. Growth response, pubertal growth and final height in Greek children with growth hormone (GH) deficiency on long-term GH therapy and factors affecting outcome.
    Karavanaki K, Kontaxaki C, Maniati-Christidi M, Petrou V, Dacou-Voutetakis C.
    J Pediatr Endocrinol Metab; 2001 Apr 01; 14(4):397-405. PubMed ID: 11327373
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature.
    Wit JM, Kamp GA, Rikken B.
    Pediatr Res; 1996 Feb 01; 39(2):295-302. PubMed ID: 8825803
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.
    J Clin Endocrinol Metab; 2001 Jul 01; 86(7):2969-75. PubMed ID: 11443153
    [Abstract] [Full Text] [Related]

  • 9. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.
    Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A.
    Horm Res; 1997 Jul 01; 48(2):62-71. PubMed ID: 9251922
    [Abstract] [Full Text] [Related]

  • 10. GH and GnRH analog treatment in children who enter puberty at short stature.
    Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Hibi I.
    J Pediatr Endocrinol Metab; 1997 Jul 01; 10(6):623-8. PubMed ID: 9467133
    [Abstract] [Full Text] [Related]

  • 11. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A, Simon D, Czernichow P.
    J Clin Endocrinol Metab; 2004 Mar 01; 89(3):1234-9. PubMed ID: 15001616
    [Abstract] [Full Text] [Related]

  • 12. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
    Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SM, Delemarre-Van de Waal HA, Verhoeven-Wind L, Zwinderman AH, Wit JM.
    Arch Dis Child; 2002 Sep 01; 87(3):215-20. PubMed ID: 12193430
    [Abstract] [Full Text] [Related]

  • 13. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A, González L, Gunczler P, Lanes R.
    J Pediatr Endocrinol Metab; 2012 Sep 01; 25(7-8):651-7. PubMed ID: 23155689
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
    Kawai M, Momoi T, Yorifuji T, Muroi J, Yamanaka C, Sasaki H, Furusho K.
    Clin Endocrinol (Oxf); 1998 Jan 01; 48(1):53-7. PubMed ID: 9509068
    [Abstract] [Full Text] [Related]

  • 15. Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment.
    Chae HW, Hwang IT, Lee JE, So CH, Rhie YJ, Lim JS, Kwon EB, Yi KH, Kim EY, Jo CK, Shim KS, Gil HY, Seong MJ, Nam CM, Moon JS, Hwang JS.
    Front Endocrinol (Lausanne); 2022 Jan 01; 13():925102. PubMed ID: 36157444
    [Abstract] [Full Text] [Related]

  • 16. The Effect of Gonadotropin-Releasing Hormone Analogue on Final Adult Height in Children with Idiopathic Short Stature.
    Khawaja N, Owaineh H, Batieha A, Frahid O, El-Khateeb M, Ajlouni KM.
    Med Princ Pract; 2019 Jan 01; 28(6):509-516. PubMed ID: 30995651
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the Final Adult Height and Its Determinants in Patients with Growth Hormone Deficiency: A Single-centre Experience from the South-Eastern Region of Turkey.
    Demiral M, Unal E, Baysal B, Baran RT, Demirbilek H, Özbek MN.
    J Clin Res Pediatr Endocrinol; 2020 Sep 02; 12(3):295-302. PubMed ID: 32157854
    [Abstract] [Full Text] [Related]

  • 18. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
    Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Katsumata N, Tachibana K, Nose O, Hibi I.
    Acta Paediatr Suppl; 1999 Feb 02; 88(428):85-8. PubMed ID: 10102060
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 2009 Feb 02; 94(2):483-90. PubMed ID: 19001519
    [Abstract] [Full Text] [Related]

  • 20. Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset.
    Li S, Wang X, Zhao Y, Ji W, Mao J, Nie M, Wu X.
    Endocrine; 2020 Sep 02; 69(3):615-624. PubMed ID: 32533506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.